The current research suggests a potential association between osteopontin 9250 C/T and IL18-137 G/C genetic polymorphisms and the occurrence of SIRS and morbidity in patients undergoing on-pump CABG. This evidence concerns the gene SPP1 and systemic inflammatory response syndrome.